Purchases and Sales Made in Q3 2022 in Diffusion Pharmaceuticals Inc. (DFFN)
This table provides information about the institutional ownership of Diffusion Pharmaceuticals Inc. (DFFN) during Q3 2022. The information is specifically focused on institutions that hold shares of Diffusion Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.75K+ 715.51% |
$9.38K - $14.7K
|
2K
$18.5K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
426+ 99.07% |
$2.28K - $3.57K
|
856
$7.92K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-4.76K- 9.77% |
$25.5K - $39.9K
|
44K
$407K
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-7.25K- 9.06% |
$38.8K - $60.7K
|
72.7K
$673K
|